EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.23.39 | Breast Neoplasms |
23811443 |
Identification of Sulfamoylbenzamide derivatives as selective Cathepsin D inhibitors. |
therapeutic application
unassigned |
4
0 |
| 3.4.23.39 | Carcinoma, Hepatocellular |
19946719 |
Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum. |
therapeutic application
unassigned |
2
0 |
| 3.4.23.39 | Gastroesophageal Reflux |
26656546 |
[FEATURES MANIFESTATIONS COMORBID CURRENTS OF GASTROESOPHAGEAL REFLUX DISEASE AND ARTERIAL HYPERTENSION DEPENDING ON THE DEGREE OF ARTERIAL HYPERTENSION]. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
1
0 |
| 3.4.23.39 | Infections |
29798744 |
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa. |
therapeutic application
unassigned |
3
0 |
| 3.4.23.39 | Infections |
31678453 |
Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: A retrospective study. |
diagnostic usage
unassigned |
3
0 |
| 3.4.23.39 | Malaria |
9561244 |
Screening aspartyl proteases with combinatorial libraries. |
unassigned |
0 |
| 3.4.23.39 | Malaria |
9873534 |
Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 3.4.23.39 | Malaria |
9886289 |
Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum. |
unassigned |
0 |
| 3.4.23.39 | Malaria |
10548045 |
Active site specificity of plasmepsin II. |
ongoing research
unassigned |
2
0 |
| 3.4.23.39 | Malaria |
11841219 |
Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
